Dr. Robin Avery is an infectious disease physician who joined the Johns Hopkins faculty in 2012, with two decades of experience in transplant infectious disease. She is a past chair of the American Society of Transplantation (AST) Infectious Disease Community of Practice, was a co-editor of the first edition of the AST ID Guidelines, and serves on a Guidelines Committee for the Infectious Disease Society of America (IDSA) on immunizations in the immunocompromised host. She was the founding head of the Transplant Infectious Disease Section at the Cleveland Clinic and served as the founding director of the Cleveland Clinic Transplant ID Special Fellowship, authoring a curriculum that served as the basis for curricula later endorsed by the AST and IDSA. Her clinical and research interests include pre-transplant donor and recipient evaluation, and prevention and treatment of post-transplant infections, particularly transplant-associated viruses, viral load monitoring, novel therapies for CMV, hypogammaglobulinemia, immunizations, and strategies for safer living post-transplant. She has a strong interest in patient education and co-authored the script for a video designed to educate patients on decreasing post-transplant infection risks. Dr. Avery is rated as a Distinguished provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, COVID-19, and Sepsis.

Eun Kim is a primary care provider, a Pediatrics specialist and a General Practice provider in Lutherville, Maryland. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Bronchitis, Acute Cystitis, Multisystem Inflammatory Syndrome in Children (MIS-C), and COVID-19.

Andrew Buscemi is a primary care provider, practicing in Family Medicine in Baltimore, Maryland. Dr. Buscemi is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Bronchitis, Multisystem Inflammatory Syndrome in Children (MIS-C), COVID-19, and Sinusitis. Dr. Buscemi is currently accepting new patients.

Allan Chircus is a primary care provider, practicing in General Practice in Timonium, Maryland. Dr. Chircus is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Peptic Ulcer, Cellulitis, Necrosis, and Otitis. Dr. Chircus is currently accepting new patients.

Yusra Azmi is a primary care provider, practicing in Internal Medicine in Timonium, Maryland. Dr. Azmi is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Edema, Heart Failure, and Hypertension. Dr. Azmi is currently accepting new patients.

Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Peripartum Cardiomyopathy, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Dr. Wendy Post is professor of medicine at the Johns Hopkins University School of Medicine and holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Lou and Nancy Grasmick Professor of Cardiology. Dr. Post is a cardiologist at the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease and the Echocardiography Laboratory and is associate faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research at Johns Hopkins University. She is Director of Cardiovascular Research for the Division of Cardiology and Director of Research for the Hopkins Cardiovascular Fellowship Training Program. Dr. Post received her undergraduate degree in biology from Harvard University. She earned her medical degree from Columbia College of Surgeons and Physicians, Columbia University. After completing her internship and residency at Harvard Medical School’s Beth Israel Hospital, Dr. Post received her master’s degree in epidemiology from the Harvard School of Public Health. She was a research fellow at the Framingham Heart Study, in Framingham, Mass., and completed a fellowship in cardiology at The Johns Hopkins Hospital. Dr. Post joined the Johns Hopkins faculty in 1997. Dr. Post’s research interests include prediction and prevention of coronary heart disease and sudden cardiac death, noninvasive imaging of subclinical atherosclerosis, genetics of cardiovascular disease, sex and racial/ethnic differences in cardiovascular disease, and cardiovascular disease in HIV/AIDS and COVID-19. She is the chair of the steering committee, and the principal investigator for the Hopkins field center for the NIH-funded Multi-Ethnic Study of Atherosclerosis (MESA). Dr. Post also leads Multicenter AIDS Cohort Study (MACS) Cardiovascular Disease sub-studies. She has been the PI for three R01 grants from NHLBI investigating cardiovascular disease in HIV, and is dual PI on the cardiology NHLBI training grant, which has been continuously funded for over 45 years. Dr. Post is a manuscript reviewer for multiple publications and is currently associate editor of Circulation. She has over 350 peer-reviewed research publications. Dr. Post was elected as a member of the American Society for Clinical Investigation (ASCI) in 2015. She mentors multiple medical students, medical house staff, fellows and junior faculty. She was a member of the Hopkins Professorial Promotions Committee and a former Johns Hopkins University Provost Fellow. She was co-chair of the Johns Hopkins University Committee on the Biomedical Scientific Workforce. Dr. Post is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Atherosclerosis, Coronary Heart Disease, Carotid Artery Disease, Hormone Replacement Therapy (HRT), and Aortic Valve Replacement.

Alexandros Samohin is a primary care provider, practicing in Family Medicine in Timonium, Maryland. Dr. Samohin is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Cellulitis, Peptic Ulcer, Necrosis, and Conjunctivitis (Pink Eye). Dr. Samohin is currently accepting new patients.

Dr. Christine Durand, associate professor of medicine and oncology and member of the Johns Hopkins Kimmel Cancer Center, is involved in clinical and translational research focused on individuals infected with HIV and hepatitis C virus who require cancer and transplant therapies. Her current research efforts include looking at outcomes of hepatitis C treatment after solid organ transplant, the potential use of organs from HIV-infected donors for HIV-infected solid organ transplant candidates, and HIV cure strategies including bone marrow transplantation. Dr. Durand is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, Tissue Biopsy, and Nephrectomy.

Qinglin Gao is a primary care provider, practicing in Internal Medicine in Timonium, Maryland. Dr. Gao is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Pleurisy, Atypical Pneumonia, Hospital-Acquired Pneumonia, Endoscopy, and Gastrostomy.

Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is rated as an Experienced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B.

Dr. Paul Auwaerter is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include Lyme disease, Epstein-Barr virus and fever of unknown origin. Dr. Auwaerter serves as the clinical director of the Division of Infectious Diseases. He is also the director of the Fisher Center for Environmental Infectious Diseases and the chief medical officer of the Point of Care-Information Technology (POC-IT) Center. He earned his M.D. from the Columbia University College of Physicians and Surgeons. His research interests include tick-borne diseases and point of care information technology. Dr. Auwaerter serves on the Clinical Compensation Subcommittee for the Johns Hopkins Department of Medicine. He was recognized with a Healthnetworks Service Excellence Award in 2014. He is a member of the American Society of Microbiology and the Infectious Diseases Society of America. Dr. Auwaerter is rated as an Experienced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Lyme Disease, Infectious Myocarditis, Babesiosis, and Osteomyelitis.

Charles Lowenstein, M.D., is a cardiologist in Baltimore, Maryland. He also serves as director of the Division of Cardiology and co-director of the Johns Hopkins Heart and Vascular Institute. Dr. Lowenstein originally came to Johns Hopkins as a cardiology fellow in 1991 after completing his medical residency at Massachusetts General Hospital and a research fellowship at the Massachusetts Institute of Technology. In 1993, he joined the Johns Hopkins faculty and helped lead the Ciccarone Center for the Prevention of Heart Disease until he was recruited in 2009 to become the chief of cardiology and director of the Aab Cardiovascular Research Institute at the University of Rochester School of Medicine and Dentistry. In 2020 he was hired to lead the Division of Cardiology at Hopkins. He has served on the NIH Atherosclerosis and Inflammation Cardiovascular Sciences study section, and is a member of the Sarnoff Cardiovascular Research Foundation, an organization that funds medical student research. Dr. Lowenstein’s research focuses on vascular biology, exploring molecular mechanisms of vascular inflammation and thrombosis. Videos Dr. Charles Lowenstein. Dr. Lowenstein is rated as an Experienced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Long QT Syndrome 3, Heart Attack, Long QT Syndrome 2, Long QT Syndrome 1, and Hormone Replacement Therapy (HRT).

Adam Faill is a primary care provider, practicing in Internal Medicine in Lutherville, Maryland. Dr. Faill is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Acute Cystitis, Bronchitis, Atypical Pneumonia, and Hospital-Acquired Pneumonia.

Tatyana Kushnir is a primary care provider, practicing in Family Medicine in Lutherville, Maryland. Dr. Kushnir is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Bronchitis, Acute Cystitis, Atypical Pneumonia, and Hospital-Acquired Pneumonia. Dr. Kushnir is currently accepting new patients.

Vasantha Udugampola is a primary care provider, practicing in Family Medicine in Lutherville, Maryland. Dr. Udugampola is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Bronchitis, Juvenile Idiopathic Arthritis (JIA), Cellulitis, and Multisystem Inflammatory Syndrome in Children (MIS-C). Dr. Udugampola is currently accepting new patients.

Haroon Akhtar is a primary care provider, practicing in Family Medicine in Lutherville, Maryland. Dr. Akhtar is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Bronchitis, Cellulitis, Familial Combined Hyperlipidemia, and Xanthoma. Dr. Akhtar is currently accepting new patients.

Jin Gu is a primary care provider, practicing in Internal Medicine in Towson, Maryland. Dr. Gu is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Hypertension, Bone Marrow Aspiration, and Endoscopy.

Aye Mon is a primary care provider, practicing in Internal Medicine in Parkville, Maryland. Dr. Mon is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are COVID-19, Dementia, Protein Deficiency, and Pericarditis. Dr. Mon is currently accepting new patients.

Fei Zhao is a primary care provider, practicing in Internal Medicine in Parkville, Maryland. Dr. Zhao is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Deep Vein Thrombosis, Dementia, Epilepsy, and Hypertension. Dr. Zhao is currently accepting new patients.